Currently, in diagnosis of HCC, the diagnostic markers used in clinical practice are mostly organ specific single indicators, for example, the most common available serum marker AFP and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in the surveillance and diagnosis of HCC20–22. Here, AFP is linked to hepatocellular carcinoma.